PALO ALTO, Calif., January 11, 2016 – NuMedii, Inc. today announced the formation of a discovery collaboration with Astellas Pharma Inc. (“Astellas”) to identify new indications for a number of undisclosed Astellas compounds using NuMedii’s predictive Big Data intelligence technology. “NuMedii’s predictive Big Data intelligence technology enables the discovery of new uses for both marketed [...]
PALO ALTO, Calif., September 29, 2015 – NuMedii, Inc. today announced the formation of a research alliance with Allergan to explore new therapeutic options for the potential treatment of psoriasis. The companies will use NuMedii’s predictive Big Data intelligence platform technology, which enables the discovery of new uses for medicines across a number of [...]
Principal Investigators David Haussler, PhD, director, UC Santa Cruz Genomics Institute Theodore Goldstein, PhD, director, MedBook Project Description Each year 500 California children with cancer either lack or fail to respond to standard therapies. Clinical trials currently underway at UC Medical Centers are starting to employ genomic analysis to identify new therapies for these [...]
Companies leverage content, Big Data analytics and expertise to improve success of drug discovery PHILADELPHIA, November 4, 2013 – The IP & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, today announced a strategic initiative with NuMedii, a biotech company dedicated to revolutionizing drug discovery, to [...]
Capital Will Be Used To Advance Internal Development Programs for Clinical Testing Company Appoints 3 New Board Members Palo Alto, CA – June 26, 2013 – NuMedii, Inc. today announced that it has recieved $3.5M in a Series A funding led by Claremont Creek Ventures and Lightspeed Venture Partners, with participation by Life Science [...]
Companies will collaborate to discover and develop new methods of treatment for certain gastrointestinal disorders and cystic fibrosis Mountain View, CA – October 03, 2012 –NuMedii, Inc. today announced a strategic alliance with Aptalis Pharma to discover and develop new methods of treatment for certain gastrointestinal disorders and cystic fibrosis. The companies will use [...]